Morgan Cheatham

Contributor

Morgan Cheatham is an investor with Bessemer Venture Partners, where he leads healthcare and life sciences investments from seed to growth stages, and in parallel, is pursuing medical training with a bioinformatics research focus at Brown.

Morgan Cheatham
AI

Six imperatives for building AI-first companies

Morgan Cheatham
Steve Kraus
9:00 am PDT • September 28, 2023

The impact of AI-first companies will be greater, financial returns superior, and moats more enduring than their AI-enabled counterparts.

Six imperatives for building AI-first companies